1 |
Akhter, S. A., Milano, C. A., Shotwell, K. F., Cho, M. C., Rockman, H. A., Lefkowitz, R. J. and Koch, W. J. Transgenic mice with cardiac overexpression ofalpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling. J. Biol. Chem. 1997, 272, 21253-21259
|
2 |
Corda, S., Mebazaa, A., Gandolfini, M. P., Fitting, C., Marotte, F., Peynet, J., Charlemagne, D., Cavaillon, J. M., Payen, D., Rappaport, L. and Samuel, J. L. Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential ole of fibroblast growth factor-2 and factors related to ventricular hypertrophy. Circ. Res. 1997, 81, 679-687
|
3 |
Hill, J. A., Karimi, M., Kutschke, W., Davisson, R. L., Zimmerman, K., Wang, Z., erber, R. E. and Weiss, R. M. Cardiac hypertrophy is not a requiredcompensatory response to short-term pressure overload. Circulation. 2000, 101, 2863-2869
|
4 |
Marian, A. J. and Roberts, R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation. 1995, 92, 1336-1347
|
5 |
Ostrom, R. S., Gregorian, C., Drenan, R. M., Xiang, Y., Regan, J. W. and Insel, P. A. Receptor number and caveolar co-localization determine receptor couplingefficiency to adenylyl cyclase. J. Biol. Chem. 2001, 276, 42063-42069.
|
6 |
De Windt, L. J., Lim, H. W., Bueno, O. F., Liang,Q., Delling, U., Braz, J. C., Glascock, B. J., Kimball, T. F., del Monte, F., Hajjar, R. J. and Molkentin, J. D. Targeted inhibition of calcineurin attenuates cardiachypertrophy in vivo. Proc. Natl. Acad. Sci. USA. 2001, 98, 3322-3327
|
7 |
Pfeffer, M. A., Frohlich, E. D., Pfeffer, J. M., Yunice, A. and Nordquist, J. A. Pathophysiological implications of the increased cardiac output of young spontaneously hypertensive rats. Circ. Res. 1974, 34/35, I235-I242
|
8 |
Ruwhof, C. and Laarse, A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc. Res. 2000, 47, 23-37
|
9 |
Kenneth, R. and Chien, M. D. Stress pathway and heart failure. Cell. 1999, 98, 555-558
|
10 |
Brilla, C. G., Janicki, J. S. and Weber, K. T. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medialthickening of intramyocardial coronary arteries. Circ Res. 1991, 69, 107-115
|
11 |
Boluyt, M. O., Bing, O. H. L. and Lakatta, E. G. The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. Eur. Heart J. 1995, 16(suppl N), 19-30
|
12 |
Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch. Biochem.Biophys. 1961, 93, 440-447
|
13 |
Hong, Y. Role of caveolin as inter/intracellular shuttle molecule on the pathogenesis of diabetes and hypertension: Characterization of the multifunctional role of caveolin isoforms. Ph.D thesis of GSNU library. 2001
|
14 |
Nishimura, H., Kubo, S., Nishioka, A., Imamura, K., Kawamura, K. and Hasegawa, M. Left ventricular diastolic function of spontaneously hypertensive rats and its relationship to structural components of the left ventricle. Clin. Sci. (Lond.). 1985, 69, 571-579
|
15 |
Clerk, A. and Sugden, P. H. Activation of protein kinase cascades in the heart by hypertrophic G proteincoupled receptor agonists. Am. J. Cardiol. 1999, 17, 64-69
|
16 |
Li, S., Galbiati, F., Volonte, D., Sargiacomo, M., Engelman, J. A., Das, K., Scherer, P. E. and Lisanti, M. P. Mutational analysis of caveolin-induced vesicleformation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes. FEBS Lett. 1998, 434, 127-134
|
17 |
Oh, P. and Schnitzer, J. E. Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol. Biol. Cell. 2001, 12, 685-698
|
18 |
Delaughter, M. C., Taffet, G. E., Fiorotto, M. L., Entman, M. L. and Schwartz, R. J. Local insulinlike growth factor I expression induces physiologic,then pathologic, cardiac hypertrophy in transgenic mice. FASEB J. 1999, 13, 1923-1929
|
19 |
Bing, O. H., Brooks, W. W., Robinson, K. G.,Slawsky, M. T., Hayes, J. A., Litwin, S. E., Sen, S. and Conrad, C. H. The spontaneously hypertensive ratas a model of the transition from compensated left ventricular hypertrophy to failure. J. Mol. Cell Cardiol. 1995, 27, 383-396.
|
20 |
Molkentin, J. D. and Dorn II G. W. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol. 2001, 63, 391-426
|
21 |
MacLellan, W. R. and Schneider, M. D. Genetic dissection of cardiac growth control pathways. Annu. Rev. Physiol. 2000, 62, 289-319
|
22 |
Kobayashi, T., Hamada, M., Okayama, H., Shigematsu, Y., Sumimoto, T. and Hiwada, K. Contractile properties of left ventricular myocytes isolated from spontaneously hypertensive rats: effect of angiotensin II. J. Hypertens. 1995, 13, 1803-1807
|